Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
Polverelli, N.; Catani, L.; Vianelli, N.; Baccarani, M.; Cavo, M.; Palandri, F.
- 期刊名称Annals of Hematology
- 作者Polverelli, N.; Catani, L.; Vianelli, N.; Baccarani, M.; Cavo, M.; Palandri, F.
- 卷第94卷
- 期第9期
- 印刷ISSN0939-5555
- 电子ISSN1432-0584
- 文件大小300.16KB
- 发表时间2015-9-16
- DOI10.1007/s00277-015-2397-9
- 页码1585-1587